Thrivent Financial for Lutherans’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,933
| Closed | -$204K | – | 2538 |
|
|
2025
Q1 | $204K | Hold |
1,933
| – | – | ﹤0.01% | 2317 |
|
|
2024
Q4 | $204K | Buy |
+1,933
| New | +$204K | ﹤0.01% | 2510 |
|
|
2023
Q2 | – | Sell |
-2,301
| Closed | -$212K | – | 2514 |
|
|
2023
Q1 | $212K | Sell |
2,301
-74
| -3% | -$6.82K | ﹤0.01% | 2375 |
|
|
2022
Q4 | $215K | Buy |
+2,375
| New | +$215K | ﹤0.01% | 2337 |
|
|
2022
Q3 | – | Sell |
-2,375
| Closed | -$201K | – | 2454 |
|
|
2022
Q2 | $201K | Sell |
2,375
-3,041
| -56% | -$257K | ﹤0.01% | 2353 |
|
|
2022
Q1 | $475K | Buy |
+5,416
| New | +$475K | ﹤0.01% | 2199 |
|
|
2021
Q1 | – | Sell |
-2,689
| Closed | -$254K | – | 2565 |
|
|
2020
Q4 | $254K | Buy |
+2,689
| New | +$254K | ﹤0.01% | 2356 |
|
|
2020
Q3 | – | Sell |
-2,723
| Closed | -$225K | – | 2408 |
|
|
2020
Q2 | $225K | Hold |
2,723
| – | – | ﹤0.01% | 2187 |
|
|
2020
Q1 | $225K | Buy |
2,723
+327
| +14% | +$27K | ﹤0.01% | 2083 |
|
|
2019
Q4 | $227K | Sell |
2,396
-1,637
| -41% | -$155K | ﹤0.01% | 2136 |
|
|
2019
Q3 | $350K | Buy |
+4,033
| New | +$350K | ﹤0.01% | 1982 |
|
|
2017
Q4 | – | Sell |
-217
| Closed | -$17K | – | 2206 |
|
|
2017
Q3 | $17K | Buy |
+217
| New | +$17K | ﹤0.01% | 2098 |
|
|
2013
Q3 | – | Sell |
-9,653
| Closed | -$611 | – | 1585 |
|
|
2013
Q2 | $611 | Buy |
+9,653
| New | +$611 | ﹤0.01% | 841 |
|